Triggers vary among asthmatics, but symptoms remain treatable - PennLive.com

PennLive.com

Triggers vary among asthmatics, but symptoms remain treatable PennLive.com “It gets called bronchitis, but it's actually asthma. It may just include a cough that won't go away.” Those symptoms, and the inflamed airways, come from “triggers.” Pollen, animal dander, mold, smoke and dust are all typical triggers. Being “allergic ...

Salt cave therapy to treat allergies - 6abc.com

6abc.com

Salt cave therapy to treat allergies 6abc.com By ALI GORMAN and CHERYL METTENDORF It's touted as an all-natural way to help relieve symptoms from allergies, asthma, even bronchitis and the common cold. So we went inside what's known as a salt cave to find out how it works.

Pulmatrix Announces Presentation of Clinical Data Demonstrating iCALM Inhaled ... - MarketWatch (press release)

Pulmatrix Announces Presentation of Clinical Data Demonstrating iCALM Inhaled ... MarketWatch (press release) Allergen-induced bronchitis was assessed by microscopic evaluation of the cellular content of sputum collected 8 hours after the inhaled allergen challenge. Pulmonary function endpoints, including forced expiratory volume in one second (FEV1), ... Pulmatrix presents iCALM clinical study resultsPharmaceutical Business Review all 7 news articles »

Pulmatrix Announces Presentation of Clinical Data Demonstrating iCALM Inhaled ... - EON: Enhanced Online News (press release)

Pulmatrix Announces Presentation of Clinical Data Demonstrating iCALM Inhaled ... EON: Enhanced Online News (press release) ... breakthrough therapies for respiratory diseases, today announced the results of a clinical study showing that an iCALM™ (inhaled cationic airway lining modulator therapy) attenuated allergen-induced bronchitis in susceptible asthmatic patients.

Sunovion Announces Upcoming Availability of ZETONNA(TM) (ciclesonide) Nasal ... - MarketWatch (press release)

Sunovion Announces Upcoming Availability of ZETONNA(TM) (ciclesonide) Nasal ... MarketWatch (press release) "With the availability of ZETONNA Nasal Aerosol, patients will have an additional treatment option available to help manage their symptoms of allergic rhinitis year-round." ZETONNA Nasal Aerosol is FDA-approved for the treatment of SAR and PAR in ... and more »